Lipid rafts and Clostridial toxins

Details for Australian Patent Application No. 2004315599 (hide)

Owner Allergan, Inc.

Inventors Li, Shengwen; Aoka, Kei Roger

Agent Davies Collison Cave

Pub. Number AU-A-2004315599

PCT Pub. Number WO2005/077416

Priority 10/732,703 10.12.03 US

Filing date 10 December 2004

Wipo publication date 25 August 2005

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/077416 Priority application(s): WO2005/077416

11 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004315614-Fluidized bed wastewater treatment

2004315596-Inhibitors of cellular necrosis